Picture of IRIDEX logo

IRIX — IRIDEX News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Iridex Corp Expected To Post A Loss Of 15 Cents A Share: Earnings Preview

* IRIDEX Corp  IRIX.OQ   IRIX.O  is expected to show a rise in
quarterly revenue when it reports results on August 12. 
* The Mountain View, California-based company is expected to
report   a 86.7% increase in revenue to $11.609 million from
$6.22 million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for IRIDEX Corp is for a
loss of 15 cents per share. For the same quarter last year, the
company reported a loss of 20 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for IRIDEX Corp is
$10.5​, about 37.4% above​ its last closing price of $6.57. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.14       -0.14      -0.14     Met     0
 Dec. 31 2020  -0.11       -0.10      -0.01     Beat    90.5
 Sep. 30 2020  -0.17       -0.17      -0.12     Beat    31.4​
 Jun. 30 2020  -0.22       -0.22      -0.20     Beat    11.1
 Mar.          -0.17​      -0.16      -0.12     Beat    27.3​
 31​ 2020​                                              
 Dec. 31 2019              -0.15      -0.11     Beat    29​
 Sep. 30 2019  -0.17       -0.17      -0.13     Beat    25.7
 Jun. 30 2019  -0.22       -0.22      -0.18     Beat    18.2
 This summary was machine generated August 10 at 21:35 GMT.  All
figures in US dollars unless otherwise stated

Recent news on IRIDEX

See all news